| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |